Home
/
Codex databases
/
Veterinary Drug Residues in Foods Database
/
Veterinary Drugs List
/
Veterinary Drugs Details
Clenbuterol (14)
Functional Classes
Maximum Residue Limits for Clenbuterol (14)
| Species | Tissues | MRL | Notes | Year |
|---|---|---|---|---|
| Cattle | Muscle | 0.2 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Horse | Liver | 0.6 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Cattle | Liver | 0.6 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Horse | Muscle | 0.2 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Horse | Kidney | 0.6 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Horse | Fat | 0.2 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Cattle | Fat | 0.2 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Cattle | Kidney | 0.6 µg/kg |
Due to the potential abuse of this drug, the MRLs are recommended only when associated with a nationally approved therapeutic use, such as tocolysis or as an adjunt therapy in respiratory diseases.
|
2003 |
| Cattle | Milk | 0.05 µg/l | 2003 |